Literature DB >> 206861

The immunological response to intact and dissociated blue-tongue virus in mice.

R A Oellermann, P Carter.   

Abstract

Antigenic fractions of bluetongue virus were separated by ultracentrifugation in Tris-buffered CsCl gradients at pH 6, 7 or 8 and the bluetongue virus polypeptide composition of the bands isolated from these gradeints was monitored by polyacrylamide gel slab electrophoresis. The immunological response to these fractions in mice was determined by a haemolytic plaque-forming cell assay, using sheep erythrocytes onto which intact bluetongue virus was adsorbed as lytic indicator cells. Isolated outer layer bluetongue virus polypeptide 2, from gradients at pH 6, and polypeptides 2 and 5, from gradients at pH 7, produced a strong primary IgM plaque-forming cell response. The subviral particles of density 1, 39 g.cm-3 and the bluetongue virus core particles of density 1,42 g.cm-3 also stimulated an IgM response at least as strong as that to intact bluetongue virus of density 1,38 g.cm-3. The isolated bluetongue virus fractions therefore appear to maintain their immunogenic integrity as effectively as those of intact bluetongue virus. The pattern of the immune response to bluetongue virus type 4 is similar to that of type 10.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 206861

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  3 in total

1.  Growth of a neuroinvasive strain of bluetongue virus in suckling mice.

Authors:  M A Carr; A W Brewer; B I Osburn
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Association of bluetongue virus gene segment 5 with neuroinvasiveness.

Authors:  M A Carr; C C de Mattos; C A de Mattos; B I Osburn
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Bluetongue virus hemagglutination and its inhibition by specific sera.

Authors:  O J Hübschle
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.